About 1,921,104 results (2,917 milliseconds)

WO2023006747A1 - Use of sglt-2 inhibitors for the prevention and ...

https://patents.google.com/patent/WO2023006747A1/en
... renal diet, diagnosed with chronic kidney disease, IRIS stage 3. According ... treatment of kidney disease in non-human mammals. MX2024001185A 2021-07 ...

WO2011107498A1 - Use of meloxicam for the long-term treatment of ...

https://patents.google.com/patent/WO2011107498A1/en
As described above, the treatment of cats suffering from kidney disease, especially CKD ... 22 cats of these cats (58%) had IRIS stage 1 -3 CKD prior to treatment ...

US9669010B2 - Treatment for chronic kidney disease - Google ...

https://patents.google.com/patent/US9669010B2/en
FIG. 7 is a chart showing the survival rate of cats with stage 3 CKD which were treated with the present composition. FIG.

WO2014064566A1 - Use of a tetrasubstituted pyrazolo[4,3-d ...

https://patents.google.com/patent/WO2014064566A1/en
... treatment of end stage renal disease. 2. 1-(2-ethoxyethyl)-5-(ethyl(methyl) ... The use according to claim 5 wherein the chronic kidney disease is stage 3 or 4.

US11801253B2 - Method of safely and effectively treating and ...

https://patents.google.com/patent/US11801253B2/en
... Chronic Kidney Disease Stages 3 and 4, Am. J. Kidney Dis., 43(5):877-890 (2004). Coburn et al., Use of active Vitamin D sterols in patients with chronic kidney ...

WO2008156868A2 - Compositions and methods of treating chronic ...

https://patents.google.com/patent/WO2008156868A2/en
Typically, hemodialysis treatment is performed about three times a week, whereas peritoneal dialysis is nearly a continuous process. End stage renal disease ...

WO2015070019A1 - Microporous zirconium silicate for the treatment ...

https://patents.google.com/patent/WO2015070019A1/en
... treatment of chronic kidney disease and/or chronic heart disease. The ... treatment in a Phase 3 trial in hyperkalaemic patients. [00357] Patients (N ...

Drug now in clinical trials for Parkinson's strengthens heart ...

https://news.google.com/articles/CBMiPmh0dHBzOi8vd3d3LnNjaWVuY2VkYWlseS5jb20vcmVsZWFzZXMvMjAxOC8wNy8xODA3MjAwOTI0NTguaHRt0gEA
Jul 20, 2018 ... Trials Reveal Efficacy and Safety of Oral Drug for Treating Anemia Associated With Kidney Disease. Aug. 6, 2021 — Pooled results from phase 3 ...

CA3201686A1 - Method for treating chronic kidney diseases ...

https://patents.google.com/patent/CA3201686A1/en
The subject may have a CKD of stage 1,2 or 3 as defined above in Table 1. Optionally, the subject has a renal fibrosis, especially a tubulointerstitial fibrosis ...

US12097177B2 - Therapeutic method for cat with chronic kidney ...

https://patents.google.com/patent/US12097177B2/en
... CKD with IRIS stage 3 in the BPS therapy group and in the No BPS therapy group. FIG. 4 is a view showing changes in stage progression-free rates of cats having ...

US9149480B2 - Use of meloxicam for the long-term treatment of ...

https://patents.google.com/patent/US9149480B2/en
... stage 1-3 renal disease. Therefore meloxicam can be used as a treatment for aged cats with painful musculoskeletal disorders and concurrent renal disease.

US9925147B2 - Method for treating secondary hyperparathyroidism ...

https://patents.google.com/patent/US9925147B2/en
... chronic kidney disease ( Stage 3, 4 or 5). The term “subject” as used herein generally includes humans, mammals (e.g., dogs, cats, rodents, sheep, horses ...

US8207149B2 - Method for treating secondary hyperparathyroidism ...

https://patents.google.com/patent/US8207149B2/en
... chronic kidney disease (Stage 3, 4 or 5). The term “subject” as used herein generally includes humans, mammals (e.g., dogs, cats, rodents, sheep, horses ...

WO2020018554A1 - Methods of treating renal disease - Google ...

https://patents.google.com/patent/WO2020018554A1/en
73 m 2. In embodiments, chronic kidney disease is stage 3 A wherein glomerular filtration rate (GFR) is from 45 to 59 ml/min/l.73 m ...

Gastroenteritis in Dogs s

https://www.google.com/share.google?q=Bi8IqgmJWLEWajf6X
Infectious diseases (i.e., canine parvovirus infection); Coagulation (blood ... Most dogs are not fed during the first 24 hours of treatment and are often given ...

US11117942B2 - AAV-EPO for treating companion animals ...

https://patents.google.com/patent/US11117942B2/en
... treating chronic kidney disease in a canine is provided. ... This study will include up to nine cats with anemia related to stage III chronic kidney disease.

‪Jessica Quimby‬ - ‪Google Scholar‬

https://scholar.google.com/citations?user=pDhRjtgAAAAJ&hl=en
... treatment of chronic kidney disease in cats: results of three sequential … JM Quimby, TL Webb, LM Habenicht, SW Dow. Stem cell research & therapy 4, 1-12, 2013.

US8877255B2 - Microporous zirconium silicate for the treatment of ...

https://patents.google.com/patent/US8877255B2/en
... patients with Stage 3 CKD. No laxative agents were given with the ZS, so the ... treatment of chronic kidney disease and / or chronic heart disease.

WO2016077126A1 - Sglt-2 inhibitors for treating metabolic disorders ...

https://patents.google.com/patent/WO2016077126A1/en
In certain embodiments, the patient has moderate renal impairment or stage 3 A chronic kidney disease (CKD). In other embodiments, the patient has moderate B ...